Search research articles
Contact Us
Filters
Showing results (171-180 of 179) with videos related to
Page
of 18
Sort By:
You have reached the last page of results.
This site can display upto 179 results.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
Alessandra Raimondi, Federico Nichetti, Arndt Stahler, et al.
Transgenic Research
|
November 26, 2008
Production of recombinant albumin by a herd of cloned transgenic cattle
Yann Echelard, Jennifer L Williams, Margaret M Destrempes, et al.
Journal of Intellectual Disability Research : JIDR
|
July 25, 2009
Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities
P Oliver-Africano, S Dickens, Z Ahmed, et al.
The Lancet. Oncology
|
June 7, 2011
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Richard A Adams, Angela M Meade, Matthew T Seymour, et al.
FEMS Microbes
|
May 8, 2026
Evidence for ecological adaptation of reductive citric acid and reverse oxidative citric acid cycles based on a survey of genomes from autotrophic <i>Bacteria</i>
Kathleen M Scott, Daniel P Walsh, Lydia Napier, et al.
Health Technology Assessment (Winchester, England)
|
April 29, 2009
Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID)
P Tyrer, P Oliver-Africano, R Romeo, et al.
Lancet (London, England)
|
June 7, 2011
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Timothy S Maughan, Richard A Adams, Christopher G Smith, et al.
Nature Biotechnology
|
May 20, 1999
Production of goats by somatic cell nuclear transfer
A Baguisi, E Behboodi, D T Melican, et al.
British Journal of Cancer
|
April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
T S Maughan, A M Meade, R A Adams, et al.
Page
of 18
Search research articles
Search
Showing results (171-180 of 179) with videos related to
Sort By:
Page
of 18
You have reached the last page of results.
This site can display upto 179 results.
European Journal of Cancer (Oxford, England : 1990)
|
July 13, 2023
Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials
Alessandra Raimondi, Federico Nichetti, Arndt Stahler, et al.
Transgenic Research
|
November 26, 2008
Production of recombinant albumin by a herd of cloned transgenic cattle
Yann Echelard, Jennifer L Williams, Margaret M Destrempes, et al.
Journal of Intellectual Disability Research : JIDR
|
July 25, 2009
Overcoming the barriers experienced in conducting a medication trial in adults with aggressive challenging behaviour and intellectual disabilities
P Oliver-Africano, S Dickens, Z Ahmed, et al.
The Lancet. Oncology
|
June 7, 2011
Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Richard A Adams, Angela M Meade, Matthew T Seymour, et al.
FEMS Microbes
|
May 8, 2026
Evidence for ecological adaptation of reductive citric acid and reverse oxidative citric acid cycles based on a survey of genomes from autotrophic <i>Bacteria</i>
Kathleen M Scott, Daniel P Walsh, Lydia Napier, et al.
Health Technology Assessment (Winchester, England)
|
April 29, 2009
Neuroleptics in the treatment of aggressive challenging behaviour for people with intellectual disabilities: a randomised controlled trial (NACHBID)
P Tyrer, P Oliver-Africano, R Romeo, et al.
Lancet (London, England)
|
June 7, 2011
Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial
Timothy S Maughan, Richard A Adams, Christopher G Smith, et al.
Nature Biotechnology
|
May 20, 1999
Production of goats by somatic cell nuclear transfer
A Baguisi, E Behboodi, D T Melican, et al.
British Journal of Cancer
|
April 19, 2014
A feasibility study testing four hypotheses with phase II outcomes in advanced colorectal cancer (MRC FOCUS3): a model for randomised controlled trials in the era of personalised medicine?
T S Maughan, A M Meade, R A Adams, et al.
Page
of 18